BG Medicine Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2011
2012
2013
2014
2015
Cash & Short Term Investments
24,439.00
13,176.00
7,751.00
4,123.00
1,525.00
Total Accounts Receivable
115.00
395.00
319.00
174.00
181.00
Inventories
212.00
447.00
459.00
400.00
145.00
Other Current Assets
550.00
558.00
306.00
154.00
100.00
Total Current Assets
25,316.00
14,576.00
8,835.00
4,851.00
1,951.00
Net Property, Plant & Equipment
301.00
197.00
192.00
117.00
11.00
Intangible Assets
456.00
372.00
192.00
135.00
77.00
Other Assets
37.00
96.00
134.00
126.00
94.00
Total Assets
26,110.00
15,241.00
9,353.00
5,229.00
2,133.00
ST Debt & Current Portion LT Debt
-
3,245.00
4,353.00
2,960.00
-
Accounts Payable
487.00
1,110.00
965.00
695.00
558.00
Other Current Liabilities
4,716.00
3,960.00
2,032.00
924.00
622.00
Total Current Liabilities
5,203.00
8,315.00
7,350.00
4,579.00
1,180.00
Long-Term Debt
-
6,612.00
2,961.00
-
-
Other Liabilities
15.00
5.00
111.00
93.00
335.00
Total Liabilities
5,218.00
14,932.00
10,422.00
4,672.00
1,515.00
Common Equity (Total)
20,892.00
309.00
1,069.00
557.00
1,976.00
Total Shareholders' Equity
20,892.00
309.00
1,069.00
557.00
618.00
Total Equity
20,892.00
309.00
1,069.00
557.00
618.00
Liabilities & Shareholders' Equity
26,110.00
15,241.00
9,353.00
5,229.00
2,133.00
Preferred Stock (Carrying Value)
-
-
-
-
2,594.00

About BG Medicine

View Profile
Address
124 Washington Street
Foxboro Massachusetts 02035
United States
Employees -
Website http://www.bg-medicine.com
Updated 07/08/2019
BG Medicine, Inc. engages in the research and development, clinical research, manufacture and sale of diagnostic products for heart failure and related disorders. It distributes its products such as BGM Galectin-3 to clinical laboratories, hospitals and health care provider. The company was founded in February 2000 and is headquartered in Waltham, MA.